Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
415 | 3426 | 55.5 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEUROAIDS | Author keyword | 139 | 74% | 3% | 104 |
2 | JOURNAL OF NEUROVIROLOGY | Journal | 123 | 28% | 11% | 378 |
3 | HIV DEMENTIA | Author keyword | 98 | 76% | 2% | 68 |
4 | HIV ASSOCIATED DEMENTIA | Author keyword | 92 | 76% | 2% | 65 |
5 | HIV ASSOCIATED NEUROCOGNITIVE DISORDERS | Author keyword | 91 | 74% | 2% | 67 |
6 | HIV ASSOCIATED NEUROCOGNITIVE DISORDER | Author keyword | 77 | 82% | 1% | 45 |
7 | AIDS DEMENTIA COMPLEX | Author keyword | 52 | 46% | 2% | 85 |
8 | HIV ENCEPHALITIS | Author keyword | 52 | 64% | 1% | 51 |
9 | HIV 1 ASSOCIATED DEMENTIA | Author keyword | 49 | 68% | 1% | 43 |
10 | NEUROVIROL NEURODEGENERAT DISORDERS | Address | 40 | 41% | 2% | 75 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEUROAIDS | 139 | 74% | 3% | 104 | Search NEUROAIDS | Search NEUROAIDS |
2 | HIV DEMENTIA | 98 | 76% | 2% | 68 | Search HIV+DEMENTIA | Search HIV+DEMENTIA |
3 | HIV ASSOCIATED DEMENTIA | 92 | 76% | 2% | 65 | Search HIV+ASSOCIATED+DEMENTIA | Search HIV+ASSOCIATED+DEMENTIA |
4 | HIV ASSOCIATED NEUROCOGNITIVE DISORDERS | 91 | 74% | 2% | 67 | Search HIV+ASSOCIATED+NEUROCOGNITIVE+DISORDERS | Search HIV+ASSOCIATED+NEUROCOGNITIVE+DISORDERS |
5 | HIV ASSOCIATED NEUROCOGNITIVE DISORDER | 77 | 82% | 1% | 45 | Search HIV+ASSOCIATED+NEUROCOGNITIVE+DISORDER | Search HIV+ASSOCIATED+NEUROCOGNITIVE+DISORDER |
6 | AIDS DEMENTIA COMPLEX | 52 | 46% | 2% | 85 | Search AIDS+DEMENTIA+COMPLEX | Search AIDS+DEMENTIA+COMPLEX |
7 | HIV ENCEPHALITIS | 52 | 64% | 1% | 51 | Search HIV+ENCEPHALITIS | Search HIV+ENCEPHALITIS |
8 | HIV 1 ASSOCIATED DEMENTIA | 49 | 68% | 1% | 43 | Search HIV+1+ASSOCIATED+DEMENTIA | Search HIV+1+ASSOCIATED+DEMENTIA |
9 | HIV 1 ENCEPHALITIS | 27 | 78% | 1% | 18 | Search HIV+1+ENCEPHALITIS | Search HIV+1+ENCEPHALITIS |
10 | GP120 | 20 | 16% | 3% | 112 | Search GP120 | Search GP120 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AIDS DEMENTIA COMPLEX | 474 | 53% | 18% | 628 |
2 | NEUROCOGNITIVE DISORDERS | 264 | 74% | 6% | 197 |
3 | AIDS DEMENTIA | 208 | 72% | 5% | 162 |
4 | HIV ASSOCIATED DEMENTIA | 141 | 68% | 4% | 125 |
5 | COAT PROTEIN GP120 | 84 | 77% | 2% | 57 |
6 | HIV 1 ASSOCIATED DEMENTIA | 80 | 70% | 2% | 66 |
7 | PROTEIN TAT | 77 | 89% | 1% | 34 |
8 | RAPID SCREENING TEST | 64 | 80% | 1% | 40 |
9 | VIRUS ASSOCIATED DEMENTIA | 53 | 89% | 1% | 24 |
10 | NEUROPATHOGENESIS | 50 | 68% | 1% | 44 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEUROVIROLOGY | 123 | 28% | 11% | 378 |
2 | JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 28 | 21% | 3% | 115 |
3 | ADVANCES IN NEUROIMMUNOLOGY | 2 | 10% | 0% | 17 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications | 2015 | 3 | 149 | 62% |
Pathways to neuronal injury and apoptosis in HIV-associated dementia | 2001 | 698 | 90 | 74% |
HIV-associated neurocognitive disorder | 2013 | 39 | 143 | 83% |
The neuropathogenesis of AIDS | 2005 | 495 | 169 | 54% |
Neurocognitive dysfunction in the highly active antiretroviral therapy era | 2012 | 42 | 23 | 100% |
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? | 2015 | 2 | 50 | 62% |
HIV-Associated Neurocognitive Disorders (HAND) | 2015 | 1 | 31 | 90% |
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND) | 2014 | 9 | 166 | 67% |
Where does HIV hide? A focus on the central nervous system | 2013 | 21 | 44 | 77% |
HIV and antiretroviral therapy in the brain: neuronal injury and repair | 2007 | 153 | 140 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROVIROL NEURODEGENERAT DISORDERS | 40 | 41% | 2.2% | 75 |
2 | PHARMACOL EXPT NEUROSCI | 23 | 19% | 3.1% | 107 |
3 | HIV NEUROBEHAV | 23 | 41% | 1.3% | 43 |
4 | MOL NEUROSCI VASC BIOL | 13 | 53% | 0.5% | 17 |
5 | NEUROIMMUNE PHARMACOL | 12 | 38% | 0.7% | 25 |
6 | NEUROAIDS SPECIALIZED NEUROSCI PROGRAM | 12 | 86% | 0.2% | 6 |
7 | HIV NEUROBEHAV PROGRAM | 11 | 56% | 0.4% | 14 |
8 | NEUROL AIDS BANK | 11 | 65% | 0.3% | 11 |
9 | NEBRASKA MED 985215 | 8 | 70% | 0.2% | 7 |
10 | TUFTS NEUROL PROGRAM | 8 | 100% | 0.1% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222612 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |
2 | 0.0000098534 | FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM |
3 | 0.0000076120 | IMMUNOBIOL ROBERT H LURIE CANC//EXPT CLIN NEUROL//MS CLIN |
4 | 0.0000057806 | HIV AFFECTED CHILDREN//PERINATALLY ACQUIRED HIV//MATERNAL HIV |
5 | 0.0000054742 | MITOCHONDRIAL TOXICITY//DISTAL SENSORY POLYNEUROPATHY//ANTIRETROVIRAL TOXIC NEUROPATHY |
6 | 0.0000051980 | TAT//TAT PROTEIN//TAR RNA |
7 | 0.0000049665 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |
8 | 0.0000043897 | RETROVIROL EPIGENET//POLYANTIGENIC IMMUNOMODULATOR//V HA RAS ONCOGENE |
9 | 0.0000042641 | HIV LATENCY//HIV CURE//HIV 1 LATENCY |
10 | 0.0000040870 | PEPTIDE T//PEPTIDE T ANALOGS//D ALA1 PEPTIDE T AMIDE |